Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 10788538)

Published in Rheumatology (Oxford) on March 01, 2000

Authors

B Willer1, G Stucki, H Hoppeler, P Brühlmann, S Krähenbühl

Author Affiliations

1: Department of Rheumatology and Physical Medicine, University Hospital of Zurich, Switzerland.

Associated clinical trials:

Can Creatine Supplementation Improve Body Composition and Physical Function in Rheumatoid Arthritis Patients? | NCT01767844

Articles by these authors

(truncated to the top 100)

ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31

Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum (2001) 4.00

Responsiveness of the WOMAC osteoarthritis index as compared with the SF-36 in patients with osteoarthritis of the legs undergoing a comprehensive rehabilitation intervention. Ann Rheum Dis (2001) 3.10

Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med (1997) 2.76

Bacterial growth on 1,2-dichloroethane. Experientia (1983) 2.74

Bile duct injury and use of cholangiography during laparoscopic cholecystectomy. Br J Surg (2010) 2.41

In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med (1997) 2.21

Density of newly synthesized plasma membrane proteins in intracellular membranes. I. Stereological studies. J Cell Biol (1984) 2.20

A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum (1995) 1.92

Predictors of surgical outcome in degenerative lumbar spinal stenosis. Spine (Phila Pa 1976) (1999) 1.92

Quantitation in immunocytochemistry: correlation of immunogold labeling to absolute number of membrane antigens. J Histochem Cytochem (1986) 1.91

Oxidative capacity of muscle and mitochondria: correlation of physiological, biochemical, and morphometric characteristics. Proc Natl Acad Sci U S A (1989) 1.83

The concept of symmorphosis: a testable hypothesis of structure-function relationship. Proc Natl Acad Sci U S A (1991) 1.80

Changes in cross-sectional measurements of the spinal canal and intervertebral foramina as a function of body position: in vivo studies on an open-configuration MR system. AJR Am J Roentgenol (1999) 1.79

Role of dissolution rate and solubility in biodegradation of aromatic compounds. Appl Environ Microbiol (1987) 1.78

Endurance training in humans: aerobic capacity and structure of skeletal muscle. J Appl Physiol (1985) (1985) 1.77

Molecular basis of skeletal muscle plasticity--from gene to form and function. Rev Physiol Biochem Pharmacol (2003) 1.71

Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology (Oxford) (2000) 1.68

Effect of tendon release and delayed repair on the structure of the muscles of the rotator cuff: an experimental study in sheep. J Bone Joint Surg Am (2004) 1.61

Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med (1995) 1.58

[Statistical deviations in high-performance athletes]. Schweiz Z Sportmed (1993) 1.57

Degenerative lumbar spinal stenosis. Diagnostic value of the history and physical examination. Arthritis Rheum (1995) 1.57

The ultrastructure of the normal human skeletal muscle. A morphometric analysis on untrained men, women and well-trained orienteers. Pflugers Arch (1973) 1.54

Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci (2006) 1.53

Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther (1995) 1.53

[International classification of functioning, disability and health and its significance for rheumatology]. Z Rheumatol (2007) 1.53

Molecular adaptations in human skeletal muscle to endurance training under simulated hypoxic conditions. J Appl Physiol (1985) (2001) 1.50

Endoscopic retroperitoneal neurectomy for chronic pain after groin surgery. Br J Surg (2009) 1.50

Effect of secretin on bile formation in rats with cirrhosis of the liver: structure-function relationship. Gastroenterology (1989) 1.45

Influences of endurance training on the ultrastructural composition of the different muscle fiber types in humans. Pflugers Arch (1985) 1.44

Human quadriceps cross-sectional area, torque and neural activation during 6 months strength training. Acta Physiol Scand (1996) 1.43

Low serum creatine kinase activity is associated with muscle weakness in patients with rheumatoid arthritis. J Rheumatol (1996) 1.40

Rehabilitation as an optimal health strategy for synergies towards implementing the World Report on Disability. Paths for dialogue with the Pontifical Council for Health Care Workers. Eur J Phys Rehabil Med (2012) 1.39

A new look at the Western Ontario and McMaster Universities Osteoarthritis Index using Rasch analysis. Arthritis Care Res (1999) 1.36

How to apply the International Classification of Functioning, Disability and Health (ICF) for rehabilitation management in clinical practice. Eur J Phys Rehabil Med (2008) 1.35

A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol (1998) 1.35

Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol (1999) 1.35

Exercise-induced ultrastructural changes in skeletal muscle. Int J Sports Med (1986) 1.32

Design of the mammalian respiratory system. VI Distribution of mitochondria and capillaries in various muscles. Respir Physiol (1981) 1.32

N-acetylglutamate synthetase deficiency: a disorder of ammonia detoxication. N Engl J Med (1981) 1.31

ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis (2010) 1.28

Measuring relevant change: an emerging challenge in rheumatologic clinical trials. Arthritis Rheum (1995) 1.28

Measuring error and sampling variation in stereology: comparison of the efficiency of various methods for planar image analysis. J Microsc (1981) 1.28

Ceiling effects of the Health Assessment Questionnaire and its modified version in some ambulatory rheumatoid arthritis patients. Ann Rheum Dis (1995) 1.28

Aerobic mineralization of 2,6-dichlorophenol by Ralstonia sp. strain RK1. Appl Environ Microbiol (1998) 1.27

Muscle structure and performance capacity of Himalayan Sherpas. J Appl Physiol (1985) (1991) 1.25

Experiences of a large-scale application of 1,2-dichloroethane degrading microorganisms for groundwater treatment. Environ Sci Technol (1995) 1.24

Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol (2006) 1.24

Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis. Rheumatology (Oxford) (2000) 1.23

Biochemical and ultrastructural changes of skeletal muscle mitochondria after chronic electrical stimulation in rabbits. Pflugers Arch (1985) 1.23

Content comparison of health-related quality of life measures used in stroke based on the international classification of functioning, disability and health (ICF): a systematic review. Qual Life Res (2007) 1.23

[Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area]. Z Rheumatol (2006) 1.18

Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol (1999) 1.18

Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med (1990) 1.17

Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin (2008) 1.17

Eccentric ergometry: increases in locomotor muscle size and strength at low training intensities. Am J Physiol Regul Integr Comp Physiol (2000) 1.17

Superior responsiveness of the pain and function sections of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) as compared to the Lequesne-Algofunctional Index in patients with osteoarthritis of the lower extremities. Osteoarthritis Cartilage (1999) 1.16

Malleability of skeletal muscle in overcoming limitations: structural elements. J Exp Biol (1985) 1.14

Design of the mammalian respiratory system. VII. Scaling mitochondrial volume in skeletal muscle to body mass. Respir Physiol (1981) 1.14

Design of the mammalian respiratory system. VIII Capillaries in skeletal muscles. Respir Physiol (1981) 1.14

Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. Am J Physiol Regul Integr Comp Physiol (2001) 1.13

The Short Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty. Arthritis Care Res (1995) 1.13

Linking osteoarthritis-specific health-status measures to the International Classification of Functioning, Disability, and Health (ICF). Osteoarthritis Cartilage (2003) 1.13

Purification and properties of acetyl-CoA:L-glutamate N-acetyltransferase from human liver. Biochem J (1982) 1.12

Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol (1998) 1.12

Design of the mammalian respiratory system. IX. Functional and structural limits for oxygen flow. Respir Physiol (1981) 1.12

Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trial. Ann Rheum Dis (2003) 1.11

Diagnosis of lumbar spinal stenosis. Rheum Dis Clin North Am (1994) 1.11

Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol (2001) 1.11

Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. Ann Rheum Dis (1996) 1.10

ICF Core Sets for individuals with spinal cord injury in the long-term context. Spinal Cord (2010) 1.09

Adaptive variation in the mammalian respiratory system in relation to energetic demand. Respir Physiol (1987) 1.09

Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. J Rheumatol (1994) 1.08

Training high--living low: changes of aerobic performance and muscle structure with training at simulated altitude. Int J Sports Med (2001) 1.08

Effects of training in normoxia and normobaric hypoxia on human muscle ultrastructure. Pflugers Arch (1993) 1.08

Responsiveness of the self-assessed rheumatoid arthritis disease activity index to a flare of disease activity. Arthritis Rheum (2001) 1.07

Acarbose and acetaminophen--a dangerous combination? Hepatology (1999) 1.07

[Vitamin E in therapy of rheumatic diseases]. Z Rheumatol (1998) 1.06

Evaluation of costs in rheumatic diseases: a literature review. Curr Opin Rheumatol (1999) 1.06

Estimating length density and quantifying anisotropy in skeletal muscle capillaries. J Microsc (1983) 1.05

Responsiveness and sensitivity to change of SLE disease activity measures. Lupus (1999) 1.04

Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. J Rheumatol (2001) 1.04

Maximal isometric muscle strength: normative values and gender-specific relation to age. Clin Rheumatol (2000) 1.04

The International Classification of Functioning Disability and Health: its development process and content validity. Eur J Phys Rehabil Med (2008) 1.03

Scaling mitochondrial volume in heart to body mass. Respir Physiol (1984) 1.03

Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI). Z Rheumatol (1999) 1.02

The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice? Rheumatology (Oxford) (2002) 1.02

Variations in function and design: testing symmorphosis in the respiratory system. Respir Physiol (1992) 1.01

Physiological profile of world-class high-altitude climbers. J Appl Physiol (1985) (1986) 1.01

The interplay of central and peripheral factors in limiting maximal O2 consumption in man after prolonged bed rest. J Physiol (1997) 0.99

Working underground: respiratory adaptations in the blind mole rat. Proc Natl Acad Sci U S A (1997) 0.99

Comparative responsiveness of 3 functional indices in ankylosing spondylitis. J Rheumatol (1999) 0.99

A guide on how to develop an International Classification of Functioning, Disability and Health Core Set. Eur J Phys Rehabil Med (2014) 0.99

Muscle ultrastructure and biochemistry of lowland Tibetans. J Appl Physiol (1985) (1996) 0.98

Disappearance of a large mediastinal pseudocyst in a patient with chronic alcoholic pancreatitis after total parenteral nutrition. Eur J Gastroenterol Hepatol (1995) 0.98

Diagnosis and therapy monitoring of Whipple's arthritis by polymerase chain reaction. Rheumatology (Oxford) (2000) 0.97

Validation of a German version of the 'Disabilities of Arm, Shoulder and Hand' questionnaire (DASH-G). Z Rheumatol (2003) 0.97

Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. Br J Cancer (2010) 0.97

[Pericarditis in chronic inflammatory bowel disease: underlying disease or side effects of therapy? Clinical problem solving]. Schweiz Med Wochenschr (1996) 0.97

Muscle tissue adaptations of high-altitude natives to training in chronic hypoxia or acute normoxia. J Appl Physiol (1985) (1996) 0.96